Critical considerations for targeting colorectal liver metastases with nanotechnology. (2020)

First Author: Arshad U
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/wnan.1588

PubMed Identifier: 31566913

Publication URI: http://europepmc.org/abstract/MED/31566913

Type: Journal Article/Review

Volume: 12

Parent Publication: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Issue: 2

ISSN: 1939-0041